It was subsequently proposed to be a novel assembly factor crucial for oxidative phosphorylation Complex I biogenesis, independent of its role in fatty acid oxidation [49]
Three patients (2%) had injected the product in a suspected self-harm attempt
The era of single-receptor incretin mimetics is likely evolving into an era of multi-receptor agonism, with Tirzepatide having paved the way
Retatrutide (development code LY3437943) is a 39-amino acid synthetic peptide developed by Eli Lilly as the first triple-receptor agonist targeting GLP-1R, GIPR, and GCGR in a single molecule
ACE inhibitors in perspective: the long and short of it
Nausea, constipation, and vomiting occur in some patients, particularly during dose escalation, but typically decrease over time or with dose adjustment